Skip to main content

Ardent Health, Inc.

For the period ended May 5, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

May 5, 2026 · Filed May 5, 2026

Use the contents to explore the available documents and sections.

ARDT$17.30+8.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Operating Statistics

Operating Statistics

(Unaudited)

Three Months Ended March 31,
2026% Change2025
Total revenue (in thousands)$1,601,8707.0%$1,497,234
Hospitals operated (at period end) (1)300.0%30
Licensed beds (at period end) (2)4,2810.0%4,281
Utilization of licensed beds (3)51%2.0%50%
Admissions (4)40,932(1.1)%41,389
Adjusted admissions (5)86,2442.0%84,536
Inpatient surgeries (6)9,2560.1%9,250
Outpatient surgeries (7)22,0861.7%21,712
Total surgeries31,3421.2%30,962
Emergency room visits (8)156,168(3.2)%161,249
Patient days (9)197,1290.5%196,214
Total encounters (10)1,564,1147.8%1,450,629
Average length of stay (11)4.821.7%4.74
Net patient service revenue per adjusted admission (12)$18,3675.5%$17,402

(1)Hospitals operated (at period end). This metric represents the total number of hospitals operated by us at the end of the applicable period, irrespective of

whether the hospital real estate is (i) owned by us, (ii) leased by us or (iii) held through a controlling interest in a JV. This metric includes the managed

clinical operations of the hospital at UT Health North Campus in Tyler, Texas ("UT Health North Campus Tyler"), a hospital owned by The University of

Texas Health Science Center at Tyler ("UTHSCT"), an affiliate of The University of Texas System. Since we only manage the clinical operations of UT Health

North Campus Tyler, the financial results of such entity are not consolidated under Ardent Health, Inc.

(2)Licensed beds (at period end). This metric represents the total number of beds for which the appropriate state agency licenses a facility, regardless of

whether the beds are actually available for patient use.

(3)Utilization of licensed beds. This metric represents a measure of the actual utilization of our inpatient facilities, computed by (i) dividing patient days by

the number of days in each period, and (ii) further dividing that number by average licensed beds, which is calculated by dividing total licensed beds (at

period end) by the number of days in the period, multiplied by the number of days in the period the licensed beds were in existence.

(4)Admissions. This metric represents the number of patients admitted for inpatient treatment during the applicable period.

(5)Adjusted admissions. This metric is used by management as a general measure of combined inpatient and outpatient volume. Adjusted admissions

provides management with a key performance indicator that considers both inpatient and outpatient volumes by applying an inpatient volume measure

(admissions) to a ratio of gross inpatient and outpatient revenue to gross inpatient revenue. Gross inpatient and outpatient revenue reflect gross inpatient

and outpatient charges prior to estimated contractual adjustments, uninsured discounts, implicit price concessions, and other discounts. The calculation of

adjusted admissions is summarized as follows:

Adjusted Admissions=Admissionsx(Gross Inpatient Revenue + Gross Outpatient Revenue)
Gross Inpatient Revenue

(6)Inpatient surgeries. This metric represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management, c-

sections, and certain diagnostic procedures are excluded from inpatient surgeries.

(7)Outpatient surgeries. This metric represents the number of surgeries performed on patients who have not been admitted to our hospitals. Pain

management, c-sections, and certain diagnostic procedures are excluded from outpatient surgeries.

(8)Emergency room visits. This metric represents the total number of patients provided with emergency room treatment during the applicable period.

(9)Patient days. This metric represents the total number of days of care provided to patients admitted to our hospitals during the applicable period.

(10)Total encounters. This metric represents the total number of events where healthcare services are rendered resulting in a billable event during the

applicable period. This includes both hospital and ambulatory patient interactions.

(11)Average length of stay. This metric represents the average number of days admitted patients stay in our hospitals.

(12)Net patient service revenue per adjusted admission. This metric represents net patient service revenue divided by adjusted admissions for the applicable

period. Net patient service revenue reflects gross inpatient and outpatient charges less estimated contractual adjustments, uninsured discounts, implicit

price concessions, and other discounts.

Three Months Ended March 31,
20262025
Net income$58,488$58,965
Adjusted EBITDA Addbacks:
Income tax expense16,10315,233
Interest expense12,21114,176
Depreciation and amortization42,98636,201
Noncontrolling interest earnings(18,638)(17,582)
Other non-operating losses (1)—217
Cybersecurity Incident recoveries, net (2)—(19,705)
Certain legal matters and related costs2,002—
Other expenses, including development, restructuring and enterprise system conversion costs (3)7,7881,407
Equity-based compensation8,9299,263
(Income) loss from disposed operations(5,883)26
Adjusted EBITDA$123,986$98,201
Total revenue$1,601,870$1,497,234
Adjusted EBITDA margin7.7%6.6%

(1)Other non-operating losses include losses realized on certain non-recurring events or events that are non-operational in nature.

(2)Cybersecurity Incident recoveries, net represent insurance recovery proceeds associated with the Cybersecurity Incident, net of incremental information

technology and litigation costs.

(3)Other expenses, including development, restructuring and enterprise system conversion costs include (i) salaries and benefits of$4.3 million for thethree

months ended March 31, 2026, (ii) professional fees of$3.3 million and$1.2 million for thethree months ended March 31, 2026 and 2025, respectively, and

(iii) other expenses of$0.2 million for each of thethree months ended March 31, 2026 and 2025.

Three Months Ended March 31, 2026
Net income$58,488
Adjusted EBITDAR Addbacks:
Income tax expense16,103
Interest expense12,211
Depreciation and amortization42,986
Noncontrolling interest earnings(18,638)
Certain legal matters and related costs2,002
Other expenses, including development, restructuring and enterprise system conversion costs (1)7,788
Equity-based compensation8,929
Income from disposed operations(5,883)
Rent expense payable to REITs (2)41,556
Adjusted EBITDAR$165,542

(1)Other expenses, including development, restructuring and enterprise system conversion costs include (i) salaries and benefits of$4.3 million, (ii)

professional fees of$3.3 million, and (iii) other expenses of$0.2 million.

(2)Rent expense payable to REITs consists of rent expense of$38.7 million related to the Ventas Master Lease and other lease agreements with Ventas for

medical office buildings and rent expense of$2.9 million related to a lease arrangement with MPT for the lease of Hackensack Meridian Mountainside

Medical Center.

(Unaudited; in millions)

Guidance for the Full Year Ending December 31, 2026
LowHigh
Net income$221$280
Adjusted EBITDA Addbacks:
Income tax expense5873
Interest expense5653
Depreciation and amortization175170
Noncontrolling interest earnings(92)(97)
Cybersecurity Incident recoveries (1)(7)(7)
Other expenses, including restructuring and enterprise system conversion costs2821
Equity-based compensation4642
Adjusted EBITDA$485$535

(1)Cybersecurity Incident recoveries represent insurance recovery proceeds associated with the Cybersecurity Incident.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.